US Broker Ratings

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Potential 27.91% Upside Amidst Robust Revenue Growth

Mettler-Toledo International, Inc. (NYSE: MTD) has long been a notable player in the diagnostics and research sector, providing precision instruments and services across the globe. Headquartered in Greifensee, Switzerland, this..

Regeneron Pharmaceuticals (REGN) Investor Outlook: Potential 17% Upside Amid Robust Pipeline

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has long been a stalwart in the biotechnology sector, and recent financial data suggests that it continues to hold significant promise for investors. With a..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a Healthy Growth Path with a $119 Billion Market Cap

HCA Healthcare, Inc. (NYSE: HCA), a stalwart in the medical care facilities industry, continues to capture the attention of investors with its robust market presence and consistent growth trajectory. With..

Merck & Company, Inc. (MRK) Stock Analysis: A Healthcare Powerhouse with 10.52% Upside Potential

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to be a focal point for investors seeking robust growth and steady income. With a staggering market..

Pfizer, Inc. (PFE) Stock Analysis: Dividend Yield Shines Amidst Mixed Valuation Signals

Pfizer, Inc. (NYSE: PFE) remains a significant player within the healthcare sector, specifically in the drug manufacturing industry. With a market capitalization of $151.14 billion, Pfizer’s footprint in the biopharmaceutical..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 51% Potential Upside in Healthcare Software

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software for the life sciences industry, is garnering significant attention from investors. With a current market capitalization of $29.4 billion, Veeva..

Alnylam Pharmaceuticals (ALNY): Investor Outlook Highlights 45.82% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering force in the biotechnology sector, offers a compelling case for investors with its innovative approach to drug development using ribonucleic acid interference (RNAi)...

Becton, Dickinson and Company (BDX) Stock Analysis: Unlocking 23.72% Potential Upside with Strong Healthcare Innovations

Becton, Dickinson and Company (NYSE: BDX), a cornerstone in the medical instruments and supplies industry, continues to command attention from investors with its robust market presence and promising growth potential...

McKesson Corporation (MCK) Stock Analysis: Navigating Growth and Opportunity with a 5.78% Potential Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a pivotal player in the medical distribution industry. With a market capitalization of $116.13 billion, McKesson’s influence extends..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unraveling a 30.74% Potential Upside in the Healthcare Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $45.82 billion, the company..

The Cigna Group (CI) Stock Analysis: Unpacking a 26.80% Potential Upside for Investors

As the healthcare sector continues to evolve, The Cigna Group (CI) stands out as a formidable player within the healthcare plans industry. With a market capitalization of $71.37 billion, this..

Sanofi (SNY) Stock Analysis: A 32% Upside Potential with a Strong Dividend Yield

Sanofi (NASDAQ: SNY), a heavyweight in the healthcare sector, presents itself as a compelling opportunity for investors seeking both stability and growth potential. With a market capitalization of $105.3 billion,..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring a 24% Potential Upside for Investors

Novo Nordisk A/S (NYSE: NVO), a powerhouse in the global healthcare sector, commands attention with its robust market cap of $169.29 billion. Known for its pioneering work in diabetes and..

Amgen Inc. (AMGN) Stock Analysis: Navigating a 106.10% Return on Equity and Healthcare Sector Dynamics

Amgen Inc. (NASDAQ: AMGN) remains a cornerstone in the healthcare sector, renowned for its robust portfolio of biopharmaceutical products. As of its latest financial release, Amgen boasts a market capitalization..

Novartis AG (NVS) Stock Analysis: A Look into the Healthcare Giant’s Growth Potential

Novartis AG, a titan in the healthcare sector, stands as a formidable player in the pharmaceuticals industry, with a robust market capitalization of $296.61 billion. With its headquarters nestled in..

Eli Lilly and Company (LLY): Analyst Consensus Highlights 23.54% Potential Upside

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, has been attracting significant attention from investors, thanks to its robust market presence and impressive growth metrics. With..

Emergent BioSolutions Inc. (EBS) Investor Outlook: Analyzing a 47.6% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector, specializes in providing preparedness and response solutions for public health threats. With a market capitalization of $426.99 million,..

Maze Therapeutics, Inc. (MAZE): Investor Outlook and Analyst Ratings Point to Strong Growth Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) is capturing the attention of investors with a compelling blend of innovation in the biotechnology sector and promising analyst ratings. Headquartered in South San Francisco,..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a 66.58% Potential Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB), a noteworthy player in the healthcare sector specializing in medical devices, offers a tantalizing prospect for investors with its potential upside of 66.58%. With a..

Tectonic Therapeutic, Inc. (TECX): Investor Outlook on a Biotech Innovator with a 129% Upside Potential

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing the attention of investors with its innovative approach in the biotechnology sector, particularly focusing on the modulation of G protein coupled receptors (GPCRs)..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds